Titan Pharmaceuticals Inc (TTNP): If preclinical testing is positive for O...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	10
Posts	1578
Boards Moderated	0
Alias Born	10/15/2014

Doctor Detroit

Re: turks post# 12336

Tuesday, 10/03/2017 10:05:54 AM

Tuesday, October 03, 2017 10:05:54 AM

If preclinical testing is positive for Opiant, then my guess would be it will be outlicensed as quickly as possible. Neither Opiant or Titan have the money to develop on their own. Maybe to Alkermes as a compliment to Vivitrol.

Keep Last Read

Replies (2) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent TTNP News

Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 09:33:11 PM
Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria • GlobeNewswire Inc. • 01/25/2024 09:29:23 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 09:59:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 10:13:45 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:30:20 PM
Titan Pharmaceuticals Announces Reverse Stock Split and Ratio • GlobeNewswire Inc. • 12/28/2023 09:15:00 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2023 09:47:46 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/17/2023 09:03:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 09:05:15 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:33:07 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:31:25 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:29:31 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:25:57 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:23:37 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 10/24/2023 09:26:34 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2023 07:07:26 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2023 09:08:35 PM
Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors • GlobeNewswire Inc. • 10/16/2023 08:37:23 PM
Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 10/04/2023 09:30:18 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/19/2023 08:41:40 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2023 08:45:22 PM
Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock • GlobeNewswire Inc. • 09/18/2023 11:30:00 AM
Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 09:30:03 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2023 08:28:25 PM

More TTNP News

InvestorsHub NewsWire

Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM

VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM

North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM

Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM

Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM

Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover